Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals

Pirfenidone (PFN) is an anti-fibrotic drug with significant anti-inflammatory property used for treatment of fibrotic conditions such as idiopathic pulmonary fibrosis (IPF). In the coronavirus disease 2019 (Covid-19) era, severe acute respiratory syndrome 2 (SARS-CoV-2) could initially lead to acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-kuraishy, Hayder M., Batiha, Gaber El-Saber, Faidah, Hani, Al-Gareeb, Ali I., Saad, Hebatallah M., Simal-Gandara, Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430017/
https://www.ncbi.nlm.nih.gov/pubmed/36044102
http://dx.doi.org/10.1007/s10787-022-01027-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430017/
https://www.ncbi.nlm.nih.gov/pubmed/36044102
http://dx.doi.org/10.1007/s10787-022-01027-6

Ejemplares similares